These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28987222)

  • 21. Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw.
    Goodday RH
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):527-36. PubMed ID: 26293331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.
    Soundia A; Hadaya D; Esfandi N; de Molon RS; Bezouglaia O; Dry SM; Pirih FQ; Aghaloo T; Tetradis S
    Bone; 2016 Sep; 90():133-41. PubMed ID: 27327410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management of third molars.
    Rafetto LK; Synan W
    Atlas Oral Maxillofac Surg Clin North Am; 2012 Sep; 20(2):197-223. PubMed ID: 23021396
    [No Abstract]   [Full Text] [Related]  

  • 24. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral and maxillofacial surgery: defining our present; shaping our future.
    White RL
    J Am Coll Dent; 2009; 76(1):36-9. PubMed ID: 19537482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective Audit: Does Prior Assessment by Oral and Maxillofacial Surgeons Reduce the Risk of Osteonecrosis of The Jaw in Patients Receiving Bone-Targeted Therapies for Metastatic Cancers to the Skeleton?--Part II.
    Turner B; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):117-22, 132. PubMed ID: 27501592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does grafting of third molar extraction sockets enhance periodontal measures in 30- to 35-year-old patients?
    Hassan KS; Marei HF; Alagl AS
    J Oral Maxillofac Surg; 2012 Apr; 70(4):757-64. PubMed ID: 22177808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
    Lee CY; Suzuki JB
    Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
    Rugani P; Kirnbauer B; Acham S; Truschnegg A; Jakse N
    J Oral Implantol; 2015 Jul; 41 Spec No():377-81. PubMed ID: 24593250
    [No Abstract]   [Full Text] [Related]  

  • 30. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Udvardy E; Redl P; Márton I
    Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of a thorough medical and pharmacological history before dental implant placement.
    Zadik Y; Abu-Tair J; Yarom N; Zaharia B; Elad S
    Aust Dent J; 2012 Sep; 57(3):388-92. PubMed ID: 22924366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebound vertebral fracture in the dental chair during a tooth extraction whilst on a treatment holiday from denosumab to avoid ONJ!
    Leaney A; Sztal-Mazer S
    Bone; 2018 Mar; 108():43. PubMed ID: 29258875
    [No Abstract]   [Full Text] [Related]  

  • 33. Controversies in osteoporosis management: concerns about bisphosphonates and when are "drug holidays" required?
    McClung M
    Clin Obstet Gynecol; 2013 Dec; 56(4):743-8. PubMed ID: 24177063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dentoalveolar surgery for the dentist: removal of third molar].
    Jansma J; Schoen PJ; Raghoebar GM; Vissink A
    Ned Tijdschr Tandheelkd; 2004 Apr; 111(4):133-40. PubMed ID: 15129558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of recombinant human bone morphogenetic protein-2 for the repair of extraction socket defects: a technical modification and case series report.
    Misch CM
    Int J Oral Maxillofac Implants; 2010; 25(6):1246-52. PubMed ID: 21197504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.